Lilly commits additional $4.5bn for US manufacturing sites
The company has also opened its first dedicated genetic medicine facility in Indiana in the US
Read More
Section: Healthcare
UCB presentation highlights impacts of epilepsy on daily life
The data underlines the consequences of disrupted sleep for patients and caregivers
Read More
Biogen agrees $850m felzartamab rights deal with TJ Biopharma
The agreement gives Biogen full global rights to the investigational antibody across immune-mediated diseases
Read More
myTomorrows partners with Rare Disease Research to boost rare disease referrals
The collaboration aims to improve patient identification and access to clinical trials
Read More
AI-powered launches on a limited budget: a playbook for emerging biopharma
Every AI decision must drive better outcomes and add greater value for clients
Read More